Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit311q32017.htm |
EX-99.1 - CERTAIN LITIGATION MATTERS - ALTRIA GROUP, INC. | exhibit991q32017.htm |
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit322q32017.htm |
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC. | exhibit321q32017.htm |
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC. | exhibit312q32017.htm |
EX-12 - STATEMENTS REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES - ALTRIA GROUP, INC. | exhibit12computationofrati.htm |
10-Q - FORM 10-Q - ALTRIA GROUP, INC. | a2017form10qq32017.htm |
Exhibit 99.2
TRIAL SCHEDULE FOR CERTAIN CASES
Below is a schedule, as of October 23, 2017, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for trial through December 31, 2017.
2017
Engle progeny
October | 0 |
November | 3 |
December | 4 |
As of October 23, 2017, there are two Engle progeny cases in trial.
Other Individual Smoking & Health
October | 0 |
November | 0 |
December | 0 |
As of October 23, 2017, there is one non-Engle progeny case in trial.